Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020647

« Back to Dashboard
NDA 020647 describes ELDEPRYL, which is a drug marketed by Somerset and is included in one NDA. It is available from one supplier. Additional details are available on the ELDEPRYL profile page.

The generic ingredient in ELDEPRYL is selegiline hydrochloride. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

Summary for NDA: 020647

selegiline hydrochloride
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020647

Suppliers and Packaging for NDA: 020647

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
selegiline hydrochloride
CAPSULE;ORAL 020647 NDA Mylan Specialty L.P. 49502-420 49502-420-60 60 CAPSULE in 1 BOTTLE (49502-420-60)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:May 15, 1996TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.